From February 8 to 11, the BioVentures team attended the 2026 AUTM Annual Meeting in Seattle to connect with peers, explore opportunities, and strengthen partnerships.
BioVentures participated in the AUTM University Conference 2025, held from October 26–29 in New Orleans. The event brought together professionals from technology transfer offices across the country to exchange knowledge, explore emerging trends, and strengthen collaboration within the tech transfer community. The conference offered a valuable opportunity to learn from experts, exchange best practices, and strengthen collaboration across the national tech transfer network. “From insightful sessions to meaningful networking moments, this experience was truly inspiring,” said Britney Bobo, Project Coordinator at BioVentures. “I had the chance to learn from industry experts, share ideas with peers, and dive deeper into the evolving world of tech transfer and innovation.” By taking part in AUTM University, BioVentures reinforces its commitment to advancing technology commercialization and promoting innovation through collaboration and professional development.
We’re proud to share that our Senior Licensing Associate, Megan Reed PhD, MBA has been selected as a 2025 recipient of the Susan Riley Keyes Memorial Fellowship from the AUTM Foundation. This highly competitive fellowship supports early-career technology transfer professionals through: • Mentorship from seasoned leaders in the field • Specialized training in invention evaluation, patenting, licensing, and commercialization • Full access to AUTM educational resources, including the Technology Transfer Practice Manual and webinar library • Registration, travel, and lodging for the AUTM Essentials Course, AUTM Annual Meeting, and regional meetings • Networking opportunities with a national cohort of fellows and industry experts Only three fellows were selected from a pool of 50 applicants, and Megan is one of them. This fellowship will deepen her expertise and broaden her professional network, further strengthening BioVentures’ ability to support UAMS innovators and drive the commercialization of life-changing biomedical technologies. Join us in congratulating Megan on LinkedIn!
BioVentures strengthens strategic direction at AUTM 2023, bolstering industry connections and insights to propel technology transfer endeavors.
